Chaturvedi Aditi, Bhawani G, Agarwal P K, Goel Shalini, Singh A, Goel R K
Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi - 221 005.
Indian J Physiol Pharmacol. 2009 Apr-Jun;53(2):137-46.
Diabetes has been reported to increase propensity to peptic ulceration through its effect both on offensive and defensive mucosal factors. Seeds of Eugenia jambolana (EJ) have been reported to have both antidiabetic as well as ulcer protective effects. The present study evaluates the antidiabetic effects of ethanolic extract of dried seed kernel of Eugenia jambolana (EJE) and its comparative effect on gastric ulceration and acid-pepsin secretion with standard antisecretory FL-blocker. Ranitidine and antidiabetic glibenclamide with a premise that Eugenia jambolana may show better ulcer healing effects by promoting defensive or reducing offensive mucosal factors in mild diabetes (MD) rats. MD was produced in adult rats by administration of streptozotocin (45 mg/kg, ip). EJE was given orally in the doses of 100-400 mg/kg for 10 days and in the dose of 200 mg/kg for 30 days respectively to study its dose- and time-dependent effects on various diabetic parameters like blood glucose, serum cholesterol and triglycerides, insulin level and glycosylated hemoglobin. For ulcer protective and gastric secretion studies, EJE (200 mg/kg) was given orally for 10 days against 2 h cold restraint stress (CRS)-, 4 h pylorus ligation (PL), aspirin (ASP, 200 mg/kg, 4 h)--and 95% ethanol (EtOH, 1 ml/200 g, 1 h)-induced gastric ulcers and offensive acid-pepsin secretion after 4 h PL with co-occurring MD in rats. EJE showed dose-dependent decrease in blood glucose level in MD rats. Blood glucose level remained stable in mild diabetic rats from 3rd day onwards after streptozotocin administration (taken as 1st day for treatment) and EJE (200 mg/kg) showed anti-hyperglycemic effect on 10th day of its administration. Further, EJE in the above dose also decreased cholesterol level with little or no effect on triglycerides level and reversed the decrease and increase in insulin and glycosylated hemoglobin level near to the normal level as observed alter 30 days treatment in MD rats. MD rats exhibited an increased propensity to gastric ulceration induced by CRS, ASP, EtOH and PL and caused increase in acid-pepsin secretion. EJE was not only effective in reversing the increased propensity to ulceration in diabetic rats but also decreased the acid-pepsin output better than glibenclamide. The ulcer protective effect of Eugenia jambolana seems to be due to its antidiabetic and gastric antisecretory effects.
据报道,糖尿病通过影响攻击性和防御性黏膜因素,增加了消化性溃疡的发病倾向。据报道,毛叶蒲桃(Eugenia jambolana,EJ)种子具有抗糖尿病和保护溃疡的作用。本研究评估了毛叶蒲桃干燥种子仁乙醇提取物(EJE)的抗糖尿病作用,以及其与标准抗分泌剂组胺H2受体阻滞剂雷尼替丁和抗糖尿病药物格列本脲相比,对胃溃疡形成及胃酸-胃蛋白酶分泌的影响,前提是毛叶蒲桃可能通过促进防御性或减少轻度糖尿病(MD)大鼠的攻击性黏膜因素,表现出更好的溃疡愈合效果。通过腹腔注射链脲佐菌素(45 mg/kg)在成年大鼠中诱导MD。分别以100 - 400 mg/kg的剂量口服EJE 10天,以及以200 mg/kg的剂量口服30天,以研究其对血糖、血清胆固醇和甘油三酯、胰岛素水平和糖化血红蛋白等各种糖尿病参数的剂量和时间依赖性影响。为了进行溃疡保护和胃分泌研究,口服给予EJE(200 mg/kg)10天,以对抗2小时冷束缚应激(CRS)、4小时幽门结扎(PL)、阿司匹林(ASP,200 mg/kg,4小时)和95%乙醇(EtOH,1 ml/200 g,1小时)诱导的胃溃疡,以及在大鼠PL 4小时后伴发MD时的攻击性胃酸-胃蛋白酶分泌。EJE使MD大鼠的血糖水平呈剂量依赖性降低。链脲佐菌素给药后(作为治疗第1天),轻度糖尿病大鼠的血糖水平从第3天起保持稳定,EJE(200 mg/kg)在给药第10天显示出抗高血糖作用。此外,上述剂量的EJE还降低了胆固醇水平,对甘油三酯水平影响很小或没有影响,并使胰岛素和糖化血红蛋白水平的降低和升高在MD大鼠30天治疗后接近正常水平。MD大鼠对CRS、ASP、EtOH和PL诱导的胃溃疡形成倾向增加,并导致胃酸-胃蛋白酶分泌增加。EJE不仅能有效逆转糖尿病大鼠增加的溃疡形成倾向,而且比格列本脲更能降低胃酸-胃蛋白酶分泌量。毛叶蒲桃的溃疡保护作用似乎归因于其抗糖尿病和胃抗分泌作用。